BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35874731)

  • 1. Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis.
    Ruan Z; Sun C; Lang Y; Gao F; Guo R; Xu Q; Yu L; Wu S; Lei T; Liu Y; Zhang M; Li H; Tang Y; Gao T; Gao Y; Lu X; Li Z; Chang T
    Front Immunol; 2022; 13():895007. PubMed ID: 35874731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalization of ocular myasthenia gravis 10 years after onset.
    Guéguen A; Hijazi B; Zuber K; Deschamps R; Lamirel C; Vignal-Clermont C; Gout O
    J Neurol; 2022 Dec; 269(12):6597-6604. PubMed ID: 36001142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis.
    Bi Z; Cao Y; Gui M; Lin J; Zhang Q; Li Y; Ji S; Bu B
    Neurol Sci; 2023 Apr; 44(4):1383-1391. PubMed ID: 36469201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation.
    Li F; Zhang H; Tao Y; Stascheit F; Han J; Gao F; Liu H; Carmona-Bayonas A; Li Z; Rueckert JC; Meisel A; Zhao S
    Ther Adv Neurol Disord; 2022; 15():17562864221104508. PubMed ID: 35755967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis.
    Zhao R; Wang Y; Huan X; Zhong H; Zhou Z; Xi J; Da Y; Lei L; Chang T; Ruan Z; Luo L; Li S; Yang H; Li Y; Luo S; Zhao C
    J Transl Med; 2021 Jun; 19(1):285. PubMed ID: 34193193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
    Guo RJ; Gao T; Ruan Z; Zhou HY; Gao F; Xu Q; Yu LP; Wu SD; Lei T; Li HH; Sun C; Zhang M; Gao YW; Lu XD; Tang YL; Tang BL; Huo FY; Zhu Y; Li ZY; Chang T
    Neurol Ther; 2022 Mar; 11(1):73-86. PubMed ID: 34729706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate.
    Li F; Li Z; Chen Y; Bauer G; Uluk D; Elsner A; Swierzy M; Ismail M; Meisel A; Rückert JC
    Eur J Cardiothorac Surg; 2020 Mar; 57(3):478-487. PubMed ID: 31628812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.
    Ding J; Zhao S; Ren K; Dang D; Li H; Wu F; Zhang M; Li Z; Guo J
    BMC Neurol; 2020 Jun; 20(1):238. PubMed ID: 32527235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
    Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
    BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
    Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
    Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy.
    Gou M; Qian N; Zhang Y; Wei L; Fan Q; Wang Z; Dai G
    Front Immunol; 2022; 13():950868. PubMed ID: 36225924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
    Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
    Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for conversion to generalization in ocular myasthenia gravis.
    Witthayaweerasak J; Rattanalert N; Aui-Aree N
    Medicine (Baltimore); 2021 May; 100(19):e25899. PubMed ID: 34106649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting the risk of postoperative myasthenic crisis in patients with thymectomy.
    Ruan Z; Su Y; Tang Y; Lin J; Lu Q; Zhou Y; Guo R; Liu Y; Li H; Sun C; Zhao Z; Li Z; Chang T
    Ann Clin Transl Neurol; 2023 Apr; 10(4):644-655. PubMed ID: 36879415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures.
    Li Q; Long X; Wang Y; Fang X; Guo D; Lv J; Hu X; Cai L
    BMC Musculoskelet Disord; 2021 Nov; 22(1):957. PubMed ID: 34784910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis: A Systematic Review and Meta-analysis.
    Fang CEH; Bokre D; Wong SH
    Neurology; 2023 Oct; 101(16):e1594-e1605. PubMed ID: 37643888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis.
    Ruan Z; Guo R; Zhou H; Gao F; Lin Y; Xu Q; Yu L; Wu S; Lei T; Zhang M; Gao Y; Lu X; Li H; Sun C; Tang B; Li Z; Chang T
    Eur J Neurol; 2022 Jun; 29(6):1805-1814. PubMed ID: 35188698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.
    Zhao S; Yan X; Ding J; Ren K; Sun S; Lu J; Zhang C; Zhang K; Li Z; Guo J
    Front Neurol; 2022; 13():857402. PubMed ID: 35547386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.